{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:17:06Z","timestamp":1788268626902,"version":"build-2803163510"},"reference-count":121,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"NNSF of China","doi-asserted-by":"publisher","award":["32070609"],"award-info":[{"award-number":["32070609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"NNSF of China","doi-asserted-by":"publisher","award":["32270648"],"award-info":[{"award-number":["32270648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that encompasses a spectrum of liver disorders, beginning with the simple steatosis, progressing to nonalcoholic steatohepatitis (NASH), and possibly leading to more severe diseases, including liver cirrhosis and hepatocellular carcinoma (HCC). In recent years, the prevalence of NAFLD has increased due to a shift towards energy-dense dietary patterns and a sedentary lifestyle. NAFLD is also strongly associated with metabolic disorders such as obesity and hyperlipidemia. The progression of NAFLD could be influenced by a variety of factors, such as diet, genetic factors, and even epigenetic factors. In contrast to genetic factors, epigenetic factors, including histone modifications, exhibit dynamic and reversible features. Therefore, the epigenetic regulation of the initiation and progression of NAFLD is one of the directions under intensive investigation in terms of pathogenic mechanisms and possible therapeutic interventions. This review aims to discuss the possible mechanisms and the crucial role of histone modifications in the framework of epigenetic regulation in NAFLD, which may provide potential therapeutic targets and a scientific basis for the treatment of NAFLD.<\/jats:p>","DOI":"10.3390\/ijms241914653","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T01:42:12Z","timestamp":1695865332000},"page":"14653","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Histone Modifications in NAFLD: Mechanisms and Potential Therapy"],"prefix":"10.3390","volume":"24","author":[{"given":"Yulei","family":"Shi","sequence":"first","affiliation":[{"name":"Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-5316","authenticated-orcid":false,"given":"Wei","family":"Qi","sequence":"additional","affiliation":[{"name":"Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2016.02.023","article-title":"Fatty liver is an independent predictor of early carotid atherosclerosis","volume":"65","author":"Pais","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"7","author":"Brunt","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: Old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2006.06.008","article-title":"Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis","volume":"4","author":"Uyeda","year":"2006","journal-title":"Cell Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/lipd.12244","article-title":"Relationships between Very Low-Density Lipoproteins-Ceramides, -Diacylglycerols, and -Triacylglycerols in Insulin-Resistant Men","volume":"55","author":"Mucinski","year":"2020","journal-title":"Lipids"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.29607","article-title":"Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science","volume":"67","author":"Siddiqui","year":"2018","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11894-022-00835-8","article-title":"Models to Predict Development or Recurence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Hepatic Fibrosis","volume":"24","author":"Yilma","year":"2022","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10620-016-4153-y","article-title":"Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease","volume":"61","author":"Hannah","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2004.04.006","article-title":"Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease","volume":"8","author":"Choudhury","year":"2004","journal-title":"Clin. Liver Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s10620-012-2112-9","article-title":"Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"57","author":"Volynets","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1096\/fj.07-102723","article-title":"Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice","volume":"22","author":"Membrez","year":"2008","journal-title":"FASEB J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1096\/fj.14-259515","article-title":"Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice","volume":"29","author":"Mazagova","year":"2015","journal-title":"FASEB J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Elinav","year":"2012","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1172\/JCI65179","article-title":"Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis","volume":"122","author":"Li","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ijo.2009.216","article-title":"Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent","volume":"34","author":"Romeo","year":"2010","journal-title":"Int. J. Obes."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: From new variants to the clinic","volume":"72","author":"Valenti","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.dld.2023.02.012","article-title":"The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease","volume":"55","author":"Balcar","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Franzago, M., Pilenzi, L., Di Rado, S., Vitacolonna, E., and Stuppia, L. (2022). The epigenetic aging, obesity, and lifestyle. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.985274"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/nu6083303","article-title":"Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition","volume":"6","author":"Lee","year":"2014","journal-title":"Nutrients"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","article-title":"Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease","volume":"62","author":"Pirola","year":"2013","journal-title":"Gut"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lee, Y.H., Jang, H.J., Kim, S., Choi, S.S., Khim, K.W., Eom, H.J., Hyun, J., Shin, K.J., Chae, Y.C., and Kim, H. (2021). Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA. Elife, 10.","DOI":"10.7554\/eLife.70472"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.aaw8806","article-title":"Dopaminylation of histone H3 in ventral tegmental area regulates cocaine seeking","volume":"368","author":"Lepack","year":"2020","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Goldsworthy, M., Absalom, N.L., Schr\u00f6ter, D., Matthews, H.C., Bogani, D., Moir, L., Long, A., Church, C., Hugill, A., and Anstee, Q.M. (2013). Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061870"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.celrep.2016.10.023","article-title":"Critical Roles of the Histone Methyltransferase MLL4\/KMT2D in Murine Hepatic Steatosis Directed by ABL1 and PPAR\u03b32","volume":"17","author":"Kim","year":"2016","journal-title":"Cell Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.30284","article-title":"UBE3A Suppresses Overnutrition-Induced Expression of the Steatosis Target Genes of MLL4 by Degrading MLL4","volume":"69","author":"Kim","year":"2019","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/hep.25754","article-title":"Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation","volume":"56","author":"Perugorria","year":"2012","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Atta, H., El-Rehany, M., Hammam, O., Abdel-Ghany, H., Ramzy, M., Roderfeld, M., Roeb, E., Al-Hendy, A., Raheim, S.A., and Allam, H. (2014). Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: Role of ASH1 and EZH2 methyltransferases repression. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112384"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1074\/jbc.RA118.002377","article-title":"Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis","volume":"293","author":"Huang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16710","DOI":"10.1074\/jbc.273.27.16710","article-title":"Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner","volume":"273","author":"Motojima","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1074\/jbc.273.10.5678","article-title":"Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"273","author":"Aoyama","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/jcmm.17676","article-title":"PRMT5 inhibition induces pro-inflammatory macrophage polarization and increased hepatic triglyceride levels without affecting atherosclerosis in mice","volume":"27","author":"Zhang","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"24154","DOI":"10.3390\/ijms141224154","article-title":"EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD","volume":"14","author":"Vella","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.25679","article-title":"Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis","volume":"56","author":"Au","year":"2012","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41389-020-00284-w","article-title":"EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200c","volume":"9","author":"Xu","year":"2020","journal-title":"Oncogenesis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1534\/genetics.108.100271","article-title":"Multiple SET methyltransferases are required to maintain normal heterochromatin domains in the genome of Drosophila melanogaster","volume":"181","author":"Riddle","year":"2009","journal-title":"Genetics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbrc.2017.02.093","article-title":"Suv39h2 deficiency ameliorates diet-induced steatosis in mice","volume":"485","author":"Shao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/hep.29127","article-title":"The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice","volume":"65","author":"Fan","year":"2017","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lim, H.J., and Kim, M. (2020). EZH2 as a Potential Target for NAFLD Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228617"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.phrs.2017.10.013","article-title":"Carnosol-mediated Sirtuin 1 activation inhibits Enhancer of Zeste Homolog 2 to attenuate liver fibrosis","volume":"128","author":"Zhao","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcmgh.2018.09.005","article-title":"Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-\u03b2 Dependent Hepatic Stellate Cell Activation and Liver Fibrosis","volume":"7","author":"Arab","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ymthe.2016.10.004","article-title":"A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A","volume":"25","author":"Zeybel","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.24792","article-title":"Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor \u03b3 in hepatic stellate cells for their antifibrotic effect","volume":"55","author":"Yang","year":"2012","journal-title":"Hepatology"},{"key":"ref_56","first-page":"388","article-title":"Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: Dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis","volume":"70","author":"Paish","year":"2021","journal-title":"Gut"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Bricambert, J., Alves-Guerra, M.C., Esteves, P., Prip-Buus, C., Bertrand-Michel, J., Guillou, H., Chang, C.J., Vander Wal, M.N., Canonne-Hergaux, F., and Mathurin, P. (2018). The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. Nat. Commun., 9.","DOI":"10.1038\/s41467-018-04361-y"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cr.2010.5","article-title":"Dual-specificity histone demethylase KIAA1718 (KDM7A) regulates neural differentiation through FGF4","volume":"20","author":"Huang","year":"2010","journal-title":"Cell Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Kim, J.H., Nagappan, A., Jung, D.Y., Suh, N., and Jung, M.H. (2021). Histone Demethylase KDM7A Contributes to the Development of Hepatic Steatosis by Targeting Diacylglycerol Acyltransferase 2. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011085"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ebiom.2018.11.055","article-title":"The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway","volume":"39","author":"Dong","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cell.2006.04.024","article-title":"Structural insights into histone demethylation by JMJD2 family members","volume":"125","author":"Chen","year":"2006","journal-title":"Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.7150\/thno.45581","article-title":"Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Deng, Y., Li, M., Zhuo, M., Guo, P., Chen, Q., Mo, P., Li, W., and Yu, C. (2021). Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression. J. Biol. Chem., 296.","DOI":"10.1074\/jbc.RA120.015335"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbrc.2019.04.105","article-title":"The histone demethylase Kdm4 suppresses activation of hepatic stellate cell by inducing MiR-29 transcription","volume":"514","author":"Kong","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kim, J.H., Jung, D.Y., Nagappan, A., and Jung, M.H. (2018). Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPAR\u03b32. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-31953-x"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kim, J.H., Jung, D.Y., Kim, H.R., and Jung, M.H. (2020). Histone H3K9 Demethylase JMJD2B Plays a Role in LXR\u03b1-Dependent Lipogenesis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218313"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1096\/fj.14-251751","article-title":"Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor \u03b3","volume":"29","author":"Jiang","year":"2015","journal-title":"FASEB J."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Viscarra, J.A., Wang, Y., Nguyen, H.P., Choi, Y.G., and Sul, H.S. (2020). Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis. Nat. Commun., 11.","DOI":"10.1038\/s41467-020-14617-1"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7150\/thno.46360","article-title":"Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis","volume":"11","author":"Jiang","year":"2021","journal-title":"Theranostics"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1172\/JCI97736","article-title":"Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid \u03b2-oxidation","volume":"128","author":"Seok","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Byun, S., Seok, S., Kim, Y.C., Zhang, Y., Yau, P., Iwamori, N., Xu, H.E., Ma, J., Kemper, B., and Kemper, J.K. (2020). Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. Nat. Commun., 11.","DOI":"10.1038\/s41467-020-14384-z"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI128073","article-title":"Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes","volume":"130","author":"Liu","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbrc.2016.11.164","article-title":"Protective effects of gomisin N against hepatic steatosis through AMPK activation","volume":"482","author":"Yun","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1248\/bpb.b15-01020","article-title":"Protective Effect of Gomisin N against Endoplasmic Reticulum Stress-Induced Hepatic Steatosis","volume":"39","author":"Jang","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2016.12.129","article-title":"Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD","volume":"483","author":"Du","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Zhou, B., Jia, L., Zhang, Z., Xiang, L., Yuan, Y., Zheng, P., Liu, B., Ren, X., Bian, H., and Xie, L. (2020). The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36. Adv. Sci., 7.","DOI":"10.1002\/advs.202002273"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.celrep.2018.12.094","article-title":"Impaired LXR\u03b1 Phosphorylation Attenuates Progression of Fatty Liver Disease","volume":"26","author":"Becares","year":"2019","journal-title":"Cell Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1194\/jlr.M093799","article-title":"FTY720\/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice","volume":"60","author":"Rohrbach","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.molmet.2018.11.001","article-title":"Tannic acid, a novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro model","volume":"19","author":"Chung","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Sharma, M., Nazareth, I., and Petersen, I. (2016). Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: A retrospective cohort study. BMJ Open, 6.","DOI":"10.1136\/bmjopen-2015-010210"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","article-title":"Mechanism by which metformin reduces glucose production in type 2 diabetes","volume":"49","author":"Hundal","year":"2000","journal-title":"Diabetes"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","article-title":"Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK)","volume":"289","author":"Cao","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Marin, T.L., Gongol, B., Zhang, F., Martin, M., Johnson, D.A., Xiao, H., Wang, Y., Subramaniam, S., Chien, S., and Shyy, J.Y. (2017). AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1. Sci. Signal., 10.","DOI":"10.1126\/scisignal.aaf7478"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","article-title":"Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/JOE-09-0345","article-title":"Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5","volume":"205","author":"Caton","year":"2010","journal-title":"J. Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.taap.2016.07.003","article-title":"Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis","volume":"306","author":"Li","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1158\/0008-5472.CAN-14-3786","article-title":"Histone Deacetylase HDAC8 Promotes Insulin Resistance and \u03b2-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma","volume":"75","author":"Tian","year":"2015","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.18632\/oncotarget.9841","article-title":"Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Liu, Y., Jiang, L., Sun, C., Ireland, N., Shah, Y.M., Liu, Y., and Rui, L. (2018). Insulin\/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis. Nat. Commun., 9.","DOI":"10.1038\/s41467-018-05309-y"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jcmgh.2020.10.006","article-title":"S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"20015","DOI":"10.1074\/jbc.M802187200","article-title":"SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase","volume":"283","author":"Hou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","article-title":"SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism","volume":"285","author":"Ponugoti","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1101\/gad.1901210","article-title":"Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid\/cholesterol regulator SREBP","volume":"24","author":"Walker","year":"2010","journal-title":"Genes Dev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1128\/MCB.00657-10","article-title":"Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress","volume":"30","author":"Schug","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1172\/JCI39319","article-title":"Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice","volume":"120","author":"Escande","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1096\/fj.201700098RR","article-title":"Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor","volume":"31","author":"Ka","year":"2017","journal-title":"FASEB J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2010.06.009","article-title":"Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis","volume":"12","author":"Kim","year":"2010","journal-title":"Cell Metab."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1016\/j.celrep.2019.11.067","article-title":"SIRT6 Promotes Hepatic Beta-Oxidation via Activation of PPAR\u03b1","volume":"29","author":"Naiman","year":"2019","journal-title":"Cell Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.molcel.2022.09.018","article-title":"Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation","volume":"82","author":"Hou","year":"2022","journal-title":"Mol. Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.molcel.2012.09.030","article-title":"The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis","volume":"48","author":"Dominy","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.23334","article-title":"Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo","volume":"51","author":"Mannaerts","year":"2010","journal-title":"Hepatology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.hbpd.2018.09.013","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-\u03b21 signal pathway","volume":"17","author":"Wang","year":"2018","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1021\/acs.jafc.8b01189","article-title":"Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor \u03b1-Mediated Activation of \u03b2 Oxidation and Suppression of Inflammation","volume":"66","author":"Sun","year":"2018","journal-title":"J. Agric. Food. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Berman, A.Y., Motechin, R.A., Wiesenfeld, M.Y., and Holz, M.K. (2017). The therapeutic potential of resveratrol: A review of clinical trials. NPJ Precis. Oncol., 1.","DOI":"10.1038\/s41698-017-0038-6"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1159\/000495898","article-title":"Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1\/ ATF6-Dependent Mechanism","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","article-title":"Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease","volume":"34","author":"Faghihzadeh","year":"2014","journal-title":"Nutr. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.dld.2014.11.015","article-title":"Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial","volume":"47","author":"Chen","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.cgh.2014.02.024","article-title":"Resveratrol does not benefit patients with nonalcoholic fatty liver disease","volume":"12","author":"Chachay","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cmet.2008.08.017","article-title":"Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation","volume":"8","author":"Feige","year":"2008","journal-title":"Cell Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"E1179","DOI":"10.1152\/ajpendo.90997.2008","article-title":"Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice","volume":"297","author":"Yamazaki","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.10.023","article-title":"PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis","volume":"66","author":"Mukhopadhyay","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.2174\/138161208786404227","article-title":"Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils","volume":"14","author":"Baser","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11010-013-1810-8","article-title":"Antihyperglycemic effect of carvacrol in combination with rosiglitazone in high-fat diet-induced type 2 diabetic C57BL\/6J mice","volume":"385","author":"Ezhumalai","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2016.10.016","article-title":"Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization","volume":"167","author":"Yang","year":"2016","journal-title":"Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0278-6915(02)00329-0","article-title":"Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids","volume":"41","author":"Sroka","year":"2003","journal-title":"Food. Chem. Toxicol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.intimp.2010.05.009","article-title":"Anti-inflammatory effects of black rice, cyanidin-3-O-beta-D-glycoside, and its metabolites, cyanidin and protocatechuic acid","volume":"10","author":"Min","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1111\/bph.15159","article-title":"Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease","volume":"177","author":"Sun","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s13577-021-00498-z","article-title":"Overexpression of ring finger protein 20 inhibits the progression of liver fibrosis via mediation of histone H2B lysine 120 ubiquitination","volume":"34","author":"Chen","year":"2021","journal-title":"Hum. Cell"},{"key":"ref_120","first-page":"1215","article-title":"Histone modifications in fatty acid synthase modulated by carbohydrate responsive element binding protein are associated with non-alcoholic fatty liver disease","volume":"42","author":"Cai","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tips.2019.12.005","article-title":"Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis","volume":"41","author":"Zarei","year":"2020","journal-title":"Trends Pharmacol. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/19\/14653\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:00:12Z","timestamp":1760130012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/19\/14653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":121,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["ijms241914653"],"URL":"https:\/\/doi.org\/10.3390\/ijms241914653","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]}}}